Targeting Lipid Metabolism in Cancer Stem Cells for Anticancer Treatment.

Autor: Singh, Manish Kumar^1,2 (AUTHOR) manishbiochem@gmail.com, Han, Sunhee^1,2,3 (AUTHOR) sunheehan@khu.ac.kr, Kim, Sungsoo^1,2,3 (AUTHOR) sgskim@khu.ac.kr, Kang, Insug^1,2,3 (AUTHOR) sgskim@khu.ac.kr

Publikováno v: International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 20, p11185. 28p.

Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015.

Autor: Dall'Era MA; Department of Urology and University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA. Electronic address: mdallera@ucdavis.edu., deVere-White R; Department of Urology and University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA., Rodriguez D; Cancer Registry of Greater California, Public Health Institute, Sacramento, CA, USA., Cress R; Cancer Registry of Greater California, Public Health Institute, Sacramento, CA, USA; Department of Public Health Sciences, School of Medicine, University of California, Davis, CA, USA.

Publikováno v: European urology focus [Eur Urol Focus] 2019 Nov; Vol. 5 (6), pp. 1014-1021. Date of Electronic Publication: 2018 May 04.

Immediate intravesical chemotherapy for low-grade bladder tumors in California: An underutilized practice and its impact on recurrence.

Autor: Yap SA; Department of Urology, University of California Davis, Sacramento, CA; University of California Davis Comprehensive Cancer Center, Sacramento, CA; Division of Urology, Department of Surgery, VA Northern California Health Care System, Sacramento, CA. Electronic address: syap@ucdavis.edu., Brunson A; Division of Hematology Oncology, Center for Oncology and Hematology Outcomes Research and Training (COHORT), UC Davis School of Medicine, Sacramento, CA., Pugashetti N; Department of Urology, University of California Davis, Sacramento, CA., Cress RD; University of California Davis Comprehensive Cancer Center, Sacramento, CA; Department of Public Health Sciences, School of Medicine, University of California Davis, Davis, CA; Public Health Institute, Cancer Registry of Greater California, Sacramento, CA., Keegan THM; Division of Hematology Oncology, Center for Oncology and Hematology Outcomes Research and Training (COHORT), UC Davis School of Medicine, Sacramento, CA., deVere White R; Department of Urology, University of California Davis, Sacramento, CA; University of California Davis Comprehensive Cancer Center, Sacramento, CA., Wun T; University of California Davis Comprehensive Cancer Center, Sacramento, CA; Division of Hematology Oncology, Center for Oncology and Hematology Outcomes Research and Training (COHORT), UC Davis School of Medicine, Sacramento, CA.

Publikováno v: Urologic oncology [Urol Oncol] 2018 Nov; Vol. 36 (11), pp. 498.e1-498.e7. Date of Electronic Publication: 2018 Sep 17.

Advances in Liquid Biopsy for Diagnosis of Bladder Cancer.

Autor: Seok, Jaekwon¹ (AUTHOR), Kwak, Yeonjoo¹ (AUTHOR), Kim, Sewhan² (AUTHOR), Kim, Eun-Mee³ (AUTHOR) esther96@kornu.ac.kr, Kim, Aram^4,5 (AUTHOR) arkim@kuh.ac.kr

Publikováno v: International Neurourology Journal. Jun2024, Vol. 28 Issue 2, p83-95. 13p.

The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer

Autor: D'Abronzo, L S, Bose, S, Crapuchettes, M E, Beggs, R E, Vinall, R L, Tepper, C G, Siddiqui, S, Mudryj, M, Melgoza, F U, Durbin-Johnson, B P, deVere White, R W, Ghosh, P M

Publikováno v: Oncogene; November 2017, Vol. 36 Issue: 46 p6359-6373, 15p